APPIAN CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that APPIAN CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $226.74M | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $50.56M | Feb 23, 2018 |
| FY2017 | Sep 30, 2017 | $44.65M | Feb 23, 2018 |
| FY2017 | Jun 30, 2017 | $43.20M | Feb 23, 2018 |
| FY2017 | Mar 31, 2017 | $38.33M | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $33.75M | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | $30.75M | Feb 23, 2018 |
| FY2017 | Jun 30, 2016 | $32.47M | Feb 23, 2018 |
| FY2017 | Mar 31, 2016 | $35.96M | Feb 23, 2018 |
| FY2017 | Dec 31, 2015 | $111.20M | Feb 23, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $726.94M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $617.02M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $545.36M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $467.99M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $369.26M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $304.57M | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $68.62M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $66.16M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $65.28M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $60.30M | Feb 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $527.34M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $448.78M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $385.02M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $334.69M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $265.17M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $215.81M | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $45.85M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $42.20M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $42.22M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $36.24M | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($92.26M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($111.44M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($150.92M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($88.64M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($33.48M) | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | ($10.80M) | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | ($14.65M) | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | ($10.05M) | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | ($15.22M) | Feb 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $609.0K | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($60.85M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($107.97M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($145.01M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($83.91M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($37.90M) | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | ($13.06M) | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | ($12.29M) | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | ($9.79M) | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | ($15.33M) | Feb 20, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $172.19M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $163.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $160.42M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $139.21M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $97.52M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $70.24M | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $15.63M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $15.70M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $12.77M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $13.96M | Feb 20, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.87M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.88M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($110.44M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($106.55M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($53.92M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($7.62M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | ($8.93M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | ($31.32M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($9.13M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($7.76M) | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.32M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $9.64M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $9.10M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $6.06M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.25M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $32.42M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $7.01M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $433.0K | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $984.0K | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $691.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $621.04M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $627.50M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $594.21M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $504.52M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $512.52M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $371.49M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $233.18M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $161.05M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $102.74M | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $738.39M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $653.68M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $575.16M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $448.51M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $270.60M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $215.92M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $166.25M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $159.99M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $115.53M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $110.82M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($46.99M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($32.64M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $52.34M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $145.70M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $233.92M | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $296.61M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $205.24M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | $73.19M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $45.52M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | ($63.49M) | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.81M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $25.56M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $27.11M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $26.35M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $27.80M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $4.86M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $0 | Feb 17, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($610.92M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($612.15M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($519.89M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($408.45M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | ($257.53M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | ($168.89M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($135.41M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | ($145.64M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($96.19M) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($64.83M) | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.81M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $118.55M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $149.35M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $148.13M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $100.80M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $112.46M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $159.76M | Feb 17, 2022 |
| FY2019 | Dec 31, 2018 | $94.93M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $73.76M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $31.14M | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $240.83M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $250.42M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $206.59M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $118.12M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Feb 16, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 17, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 17, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2024 | 74.00M | Feb 19, 2025 |
| FY2017 | Dec 31, 2017 | 0 | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | 34.27M | Feb 23, 2018 |